SUPPRELIN LA
Active substance: histrelin
IMPLANT · HISTRELIN ACETATE 50 mg/1
United StatesActive
Marketing holder: Endo USA, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- HISTRELIN ACETATE · 50 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12099-3004-75dd-9178-5088b21237a9;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 67979-002
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 67979-002 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 67979-002 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 67979-002 · Verified 2026-10-09 · open in source